Hans Biomed Corp (042520)

KOSDAQ
Currency in KRW
9,700
-50(-0.51%)
Delayed Data·
042520 Scorecard
Full Analysis
Net income is expected to grow this year
042520 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9,5109,960
52 wk Range
6,18013,100
Key Statistics
Edit
Bid/Ask
9,680.00 / 9,700.00
Prev. Close
9,750
Open
9,770
Day's Range
9,510-9,960
52 wk Range
6,180-13,100
Volume
18.81K
Average Volume (3m)
25.05K
1-Year Change
-25.12%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
042520 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Hans Biomed Corp News & Analysis

No news in this category
Looks like there are no results in this news category

Hans Biomed Corp Company Profile

HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. The company provides ExFuse, a demineralized bone matrix with cancellous bone gel/putty; BellaFuse, a demineralized bone matrix; Genesis, a cancellous sponge block/filler; Pedi-Stick, a demineralized cortical bone stick; SureChip, a cancellous bone chip; OsteoGrow, a demineralized bone matrix inserter; BellaCell HD, an allograft dermal product that transplanted in a patient whose skin has been lost due to breast cancer; and SureDerm, an acellular dermal matrix. It also offers BELLAGEL, a breast prosthesis, internal, and gel-filled solution; MINT Lift, a PDO thread; EZ-Tcon solution; Lion HT/HN, a hair transplanter body/needle; and Scar Clinic, a scar management solution. The company was formerly known as Hans Medical Corp. and changed its name to HansBiomed Corporation in June 2000. The company was founded in 1990 and is headquartered in Seoul, South Korea.

Compare 042520 to Peers and Sector

Metrics to compare
042520
Peers
Sector
Relationship
P/E Ratio
−19.1x−7.3x−0.5x
PEG Ratio
−0.50−0.070.00
Price/Book
1.9x2.2x2.6x
Price / LTM Sales
1.5x6.9x3.1x
Upside (Analyst Target)
-0.0%51.1%
Fair Value Upside
Unlock8.1%8.9%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
64.00 / --
Revenue / Forecast
24.16B / --
EPS Revisions
Last 90 days

042520 Income Statement

FAQ

What Is the Hans Biomed (042520) Stock Price Today?

The Hans Biomed stock price today is 9,700.00

What Stock Exchange Does Hans Biomed Trade On?

Hans Biomed is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Hans Biomed?

The stock symbol for Hans Biomed is "042520."

What Is the Hans Biomed Market Cap?

As of today, Hans Biomed market cap is 126.62B.

What Is Hans Biomed's Earnings Per Share (TTM)?

The Hans Biomed EPS (TTM) is -510.64.

When Is the Next Hans Biomed Earnings Date?

Hans Biomed will release its next earnings report on 18 Aug 2025.

From a Technical Analysis Perspective, Is 042520 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Hans Biomed Stock Split?

Hans Biomed has split 0 times.

How Many Employees Does Hans Biomed Have?

Hans Biomed has 263 employees.

What is the current trading status of Hans Biomed (042520)?

As of 16 Jun 2025, Hans Biomed (042520) is trading at a price of 9,700.00, with a previous close of 9,750.00. The stock has fluctuated within a day range of 9,510.00 to 9,960.00, while its 52-week range spans from 6,180.00 to 13,100.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.